Eurocine Vaccines

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs.

The vaccines are developed up to proof of concept and licensed to partners for further development and commercialization. The company’s proprietary vaccine adjuvant technology Endocine™, which is a key element of the nasal vaccines, is also offered to license partners for development in various indications.